Investigators revealed a previously unrecognized non-canonical metabolic function of 3-phosphoglycerate dehydrogenase (PHGDH), thus providing potential therapeutic targets in the tumor microenvironment for reversing malignant progression.
[Cancer Biology & Medicine]